Why the study?
Right ventricular pacing is associated with the progression of tricuspid regurgitation, whereas left bundle branch area pacing is considered more physiological, prompting investigation into tricuspid regurgitation variation and associated clinical outcomes after left bundle branch area pacing implantation.
Does left bundle branch area pacing improve tricuspid regurgitation severity and pressure gradient compared with right ventricular pacing in patients receiving a new pacemaker?
Does left bundle branch area pacing improve tricuspid regurgitation severity and pressure gradient compared with right ventricular pacing in patients receiving a new pacemaker?
Answers are grounded in this paper and cite their sources.
LBBAP may prevent tricuspid regurgitation progression and improve TR severity compared to traditional RVP, potentially reducing heart failure hospitalizations.
Right ventricular pacing (RVP) is associated with the progression of tricuspid regurgitation (TR). Left bundle branch area pacing (LBBAP) has been considered a more physiological procedure. Hence, we aimed to investigate the TR variation and associated clinical outcomes after LBBAP implantation. We retrospectively analyzed 492 patients receiving a new pacemaker implantation between 2018 January and 2024 December, consisting of 241 patients with LBBAP and 251 patients with RVP. Primary outcomes were the deterioration or regression of TR grade, and the progression of tricuspid regurgitation pressure gradient (TRPG). During a mean follow-up period of 2.17 ± 0.87 years, the LBBAP group had a lower incidence of TRPG progression (P = 0.010), and a higher incidence of TR regression (P = 0.016) compared with the RVP group. Kaplan–Meier survival curve analysis revealed that the LBBAP group had a lower cumulative incidence of TRPG progression compared with the RVP group (Log-rank test, P = 0.023). Furthermore, the patients with TRPG progression had a higher cumulative incidence of heart failure hospitalization compared with those without TRPG progression (Log-rank test, P < 0.001). Only in patients with heart failure with reduced ejection fraction, the incidence of TR progression was lower in the LBBAP group than the RVP group (P = 0.019). In this study, we found that LBBAP, compared with RVP, may prevent TRPG progression, have the benefit of TR improvement, and decrease TR progression in patients with heart failure with reduced ejection fraction, probably leading to decrease heart failure hospitalization.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: